Kolexia
Lemarie Jeremie Cardiologie
Lemarie Jeremie
Cardiologie
Hôpital Hôtel-Dieu Nantes
Nantes, France
111 Activités
83 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infarctus du myocarde Infarctus Choc septique Sepsie Remodelage ventriculaire Pneumopathie infectieuse Choc Maladie grave Inflammation

Collaborateurs

Voir plus
Gibot Sebastien
Gibot Sebastien
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Bollaert Pierre
Bollaert Pierre
Hôpital Central, Nancy, France
Lascarrou Jean-Baptiste
Lascarrou Jean-Baptiste
Hôpital Hôtel-Dieu Nantes, Nantes, France
Reignier Jean
Reignier Jean
Hôpital Hôtel-Dieu Nantes, Nantes, France

Industries

Voir plus
Servier
2 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Immediate vs. culture-initiated antibiotic therapy in suspected non-severe ventilator-associated pneumonia: a before-after study (DELAVAP).
Annals of intensive care   27 février 2024
Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterobacterales in critically ill patients: a prospective multicenter observational study.
Critical care (London, England)   05 février 2024
Extracranial anticoagulant related bleedings admitted to intensive care units: a French multicenter retrospective study.
Critical care (London, England)   09 août 2023
Extra-cerebral anticoagulant related bleeding accidents admitted to intensive care units: a French multicenter retrospective study 2007–2018
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Aggressive versus restrictive initiation of antimicrobial treatment in critically ill patients with suspected ventilator acquired pneumonia without severity: a before/after observational study
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
De-escalation of β-lactams in wild-type AmpC-producing Enterobacterales ventilator associated pneumonia in critically ill patients: a prospective multicenter study
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Association between physical strength and quality of life three months after ICU discharge
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial.
The Lancet. Respiratory medicine   31 mai 2023
Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial.
EClinicalMedicine   31 mai 2023
ESSENTIAL: Efficacy and Safety Study Exploring Nangibotide Treatment in COVID-19 pAtients With ventiLatory Support (ESSENTIAL) A Randomized, Double-blind, Placebo-controlled Study With Adaptive Features
Essai Clinique (Inotrem)   02 mai 2023